Geron Corp. (GERN)

1.43
NASDAQ : Health Technology
Prev Close 1.49
Day Low/High 1.42 / 1.50
52 Wk Low/High 0.95 / 2.14
Avg Volume 1.44M
Exchange NASDAQ
Shares Outstanding 188.42M
Market Cap 280.75M
EPS -0.10
P/E Ratio N/A
Div & Yield N.A. (N.A)
Interesting GERN Put And Call Options For January 2017

Interesting GERN Put And Call Options For January 2017

Investors in Geron Corp. saw new options begin trading today, for the January 2017 expiration.

The Shuman Law Firm Investigates Geron Corp.

The Shuman Law Firm Investigates Geron Corp.

The Shuman Law Firm announces that it is investigating potential claims against certain officers and directors of Geron Corp.

Geron Corporation Reports First Quarter 2015 Financial Results And Recent Events

Geron Corporation Reports First Quarter 2015 Financial Results And Recent Events

Upcoming Investor Conference and Annual Stockholders Meeting Also Announced

First Week of GERN May 15th Options Trading

First Week of GERN May 15th Options Trading

Investors in Geron Corp. saw new options begin trading this week, for the May 15th expiration.

Weak On High Volume: Geron (GERN)

Weak On High Volume: Geron (GERN)

Trade-Ideas LLC identified Geron (GERN) as a weak on high relative volume candidate

First Week of GERN June 19th Options Trading

First Week of GERN June 19th Options Trading

Investors in Geron Corp. saw new options begin trading this week, for the June 19th expiration.

Today's Dead Cat Bounce Stock: Geron (GERN)

Today's Dead Cat Bounce Stock: Geron (GERN)

Trade-Ideas LLC identified Geron (GERN) as a "dead cat bounce" (down big yesterday but up big today) candidate

First Week of September 18th Options Trading For Geron (GERN)

First Week of September 18th Options Trading For Geron (GERN)

Investors in Geron Corp. saw new options become available this week, for the September 18th expiration.

Geron (GERN) Is Strong On High Volume Today

Geron (GERN) Is Strong On High Volume Today

Trade-Ideas LLC identified Geron (GERN) as a strong on high relative volume candidate

Commit To Buy Geron At $2.50, Earn 16.4% Annualized Using Options

Commit To Buy Geron At $2.50, Earn 16.4% Annualized Using Options

Investors considering a purchase of Geron Corp. shares, but tentative about paying the going market price of $3.57/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Trade-Ideas: Geron (GERN) Is Today's "Dead Cat Bounce" Stock

Trade-Ideas: Geron (GERN) Is Today's "Dead Cat Bounce" Stock

Trade-Ideas LLC identified Geron (GERN) as a "dead cat bounce" (down big yesterday but up big today) candidate

Geron (GERN) Is Today's Perilous Reversal Stock

Geron (GERN) Is Today's Perilous Reversal Stock

Trade-Ideas LLC identified Geron (GERN) as a "perilous reversal" (up big yesterday but down big today) candidate

Geron (GERN) Flagged As Strong On High Volume

Geron (GERN) Flagged As Strong On High Volume

Trade-Ideas LLC identified Geron (GERN) as a strong on high relative volume candidate

3 Health Care Stocks Under $10 to Watch: MannKind and More

3 Health Care Stocks Under $10 to Watch: MannKind and More

Keep an eye on these under-$10 health care stocks making big moves to the upside.

Trade-Ideas: Geron (GERN) Is Today's Strong On High Relative Volume Stock

Trade-Ideas: Geron (GERN) Is Today's Strong On High Relative Volume Stock

Trade-Ideas LLC identified Geron (GERN) as a strong on high relative volume candidate

Today's Dead Cat Bounce Stock: Geron (GERN)

Today's Dead Cat Bounce Stock: Geron (GERN)

Trade-Ideas LLC identified Geron (GERN) as a "dead cat bounce" (down big yesterday but up big today) candidate

Geron (GERN) Showing Signs Of A Dead Cat Bounce Today

Geron (GERN) Showing Signs Of A Dead Cat Bounce Today

Trade-Ideas LLC identified Geron (GERN) as a "dead cat bounce" (down big yesterday but up big today) candidate

Strong On High Relative Volume: Geron (GERN)

Strong On High Relative Volume: Geron (GERN)

Trade-Ideas LLC identified Geron (GERN) as a strong on high relative volume candidate

Geron (GERN) Stock Surges Following Johnson & Johnson Licensing Deal

Geron (GERN) Stock Surges Following Johnson & Johnson Licensing Deal

Shares of Geron (GERN) soared in morning trading Monday after the company announced late last week it had licensed its blood disorder drug imetelstat to Johnson & Johnson JNJ.

Stock Market Today: Stocks Mixed as Retail Sales Climb, House OKs Keystone Pipeline

Stock Market Today: Stocks Mixed as Retail Sales Climb, House OKs Keystone Pipeline

U.S. stocks fluctuate on Friday, caught between better-than-expected retail sales and more worries of eurozone deflation.

Geron (GERN) Is Today's Pre-Market Mover With Heavy Volume Stock

Geron (GERN) Is Today's Pre-Market Mover With Heavy Volume Stock

Trade-Ideas LLC identified Geron (GERN) as a pre-market mover with heavy volume candidate

Geron Licenses Experimental Myelofibrosis Drug to Johnson & Johnson

Geron Licenses Experimental Myelofibrosis Drug to Johnson & Johnson

J&J is paying $35 million upfront to Geron for rights to the drug.

After A Long Year, an Update on Geron's Myelofibrosis Drug Is Disclosed

After A Long Year, an Update on Geron's Myelofibrosis Drug Is Disclosed

The new imetelstat data in myelofibrosis are contained in a just-released research abstract ahead of next month's American Society of Hematology ASH annual meeting.

Trade-Ideas: Geron (GERN) Is Today's "Perilous Reversal" Stock

Trade-Ideas: Geron (GERN) Is Today's "Perilous Reversal" Stock

Trade-Ideas LLC identified Geron (GERN) as a "perilous reversal" (up big yesterday but down big today) candidate

Geron (GERN) Stock Surges After FDA Removes Full Clinical Hold on Imetelstat Application

Geron (GERN) Stock Surges After FDA Removes Full Clinical Hold on Imetelstat Application

Shares of Geron (GERN) soared in morning trading Monday after the FDA removed its full clinical hold on the company's investigational new drug application for imetelstat.

Geron (GERN) Strong On High Relative Volume Today

Geron (GERN) Strong On High Relative Volume Today

Trade-Ideas LLC identified Geron (GERN) as a strong on high relative volume candidate

Yellen, Icahn Comments Put a Lid on Small-Cap Stocks, May Hurt Larger Market

Yellen, Icahn Comments Put a Lid on Small-Cap Stocks, May Hurt Larger Market

Recent comments by Fed Chair Janet Yellen and activist investor Carl Icahn have led to selling pressure in small-cap stocks.

Stock Market Today: Social Media, Biotech Suffer as Janet Yellen Shares Concerns on Valuation

Stock Market Today: Social Media, Biotech Suffer as Janet Yellen Shares Concerns on Valuation

Major indices trembled and the Nasdaq slid Tuesday following Fed Chair Janet Yellen's remarks on biotech and social media valuations.

TheStreet Quant Rating: D (Sell)